We disclose the use of a strain of bacteriophages in the manufacturing of a preparation for improving the state of health of patients infected with adenoviruses, wherein preferably the preparation produced is used for the treatment or prevention of adenoviral infections, particularly those caused by HAdV, preferably HAdV-5.
申请公布号
WO2014195871(A1)
申请公布日期
2014.12.11
申请号
WO2014IB61922
申请日期
2014.06.03
申请人
WARSZAWSKI UNIWERSYTET MEDYCZNY;INSTYTUT IMMUNOLOGII I TERAPII DO&Sacute,WIADCZALNEJ IM LUDWIKA HIRSZFELDA PAN WE WROC&Lstrok,AWIU
发明人
JAKUBOWSKA-ZAHORSKA, RENATA;PRZYBYLSKI, MACIEJ;BORYSOWSKI, JAN;GÓRSKI, ANDRZEJ
